{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:03:35Z","timestamp":1778717015893,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.ijcard.2015.05.141","type":"journal-article","created":{"date-parts":[[2015,5,29]],"date-time":"2015-05-29T00:52:08Z","timestamp":1432860728000},"page":"127-131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"special_numbering":"C","title":["Comparison of dabigatran versus warfarin in diabetic patients with atrial fibrillation: Results from the RE-LY trial"],"prefix":"10.1016","volume":"196","author":[{"given":"Michela","family":"Brambatti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harald","family":"Darius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas","family":"Oldgren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Clemens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herbert H.","family":"Noack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Brueckmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salim","family":"Yusuf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Wallentin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael D.","family":"Ezekowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart J.","family":"Connolly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeff S.","family":"Healey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2015.05.141_bb0005","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham Study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"},{"key":"10.1016\/j.ijcard.2015.05.141_bb0010","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1093\/eurheartj\/ehi505","article-title":"Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on atrial fibrillation","volume":"26","author":"Nieuwlaat","year":"2005","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2015.05.141_bb0015","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.amjcard.2012.11.026","article-title":"Frequency, patient characteristics, treatment strategies, and resource usage of atrial fibrillation (from The Italian Survey of Atrial Fibrillation Management [ISAF] Study)","volume":"111","author":"Zoni-Berisso","year":"2013","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2015.05.141_bb0020","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1161\/CIRCULATIONAHA.110.009035","article-title":"Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: the Atherosclerosis Risk in Communities (ARIC) Study","volume":"123","author":"Huxley","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2015.05.141_bb0025","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.amjcard.2011.03.004","article-title":"Meta-analysis of cohort and case\u2013control studies of type 2 diabetes mellitus and risk of atrial fibrillation","volume":"108","author":"Huxley","year":"2011","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2015.05.141_bb0030","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1212\/01.wnl.0000267275.68538.8d","article-title":"Independent predictors of stroke in patients with atrial fibrillation: a systematic review","volume":"69","author":"Stroke Risk in Atrial Fibrillation Working Group","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.ijcard.2015.05.141_bb0035","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1161\/STROKEAHA.107.501825","article-title":"Comparison of 12 risk stratification schemes to predict stroke in patients with nonvalvular atrial fibrillation","volume":"39","author":"Stroke Risk in Atrial Fibrillation Working Group","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.ijcard.2015.05.141_bb0040","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.ijcard.2015.05.141_bb0045","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cjca.2012.01.021","article-title":"Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate\/rhythm control","volume":"28","author":"Skanes","year":"2012","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.ijcard.2015.05.141_bb0050","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1016\/j.jacc.2010.09.013","volume":"57","author":"Fuster","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2015.05.141_bb0055","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1161\/01.STR.27.2.210","article-title":"Diabetes mellitus as a risk factor for death from stroke. Prospective study of the middle-aged Finnish population","volume":"27","author":"Tuomilehto","year":"1996","journal-title":"Stroke"},{"key":"10.1016\/j.ijcard.2015.05.141_bb0060","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1161\/01.STR.25.10.1977","article-title":"Stroke in patients with diabetes. The Copenhagen Stroke Study","volume":"25","author":"Jorgensen","year":"1994","journal-title":"Stroke"},{"key":"10.1016\/j.ijcard.2015.05.141_bb0065","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.0954-6820.1980.tb09749.x","article-title":"The natural history of stroke in diabetic patients","volume":"207","author":"Asplund","year":"1980","journal-title":"Acta Med. Scand."},{"key":"10.1016\/j.ijcard.2015.05.141_bb0070","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijcard.2015.05.141_bb0075","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1161\/CIRCULATIONAHA.112.115410","article-title":"Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of the literature","volume":"126","author":"Dentali","year":"2012","journal-title":"Circulation"},{"issue":"9921","key":"10.1016\/j.ijcard.2015.05.141_bb0080","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2015.05.141_bb0085","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2015.05.141_bb0090","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1056\/NEJMc1007378","article-title":"Newly Identified Events in the RE-LY Trial","volume":"363","author":"Connolly","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2015.05.141_bb0095","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.ahj.2009.02.005","article-title":"Rationale and design of RE-LY: randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran","volume":"157","author":"Ezekowitz","year":"2009","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2015.05.141_bb0100","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","article-title":"Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies","volume":"375","author":"Emerging Risk Factors Collaboration","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2015.05.141_bb0105","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1161\/01.STR.0000057975.15221.40","article-title":"Association between diabetes and stroke subtype on survival and functional outcome 3months after stroke: data from the European BIOMED Stroke Project","volume":"34","author":"Megherbi","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.ijcard.2015.05.141_bb0110","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S1056-8727(00)00132-X","article-title":"Diabetes mellitus: a hypercoagulable state","volume":"15","author":"Carr","year":"2001","journal-title":"J. Diabetes Complicat."},{"key":"10.1016\/j.ijcard.2015.05.141_bb0115","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1161\/hs1001.097090","article-title":"Evaluation of risk factors for stroke\/embolism and of complications due to anticoagulant therapy in atrial fibrillation","volume":"32","author":"Wehinger","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.ijcard.2015.05.141_bb0120","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1055\/s-0037-1615599","article-title":"Oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and risk of bleeding. A Multicenter Inception Cohort Study","volume":"85","author":"Pengo","year":"2001","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ijcard.2015.05.141_bb0125","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0002-9343(98)00198-3","article-title":"Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin","volume":"105","author":"Beyth","year":"1998","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ijcard.2015.05.141_bb0130","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.ijcard.2015.05.141_bb0135","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jacc.2011.03.031","article-title":"A new risk scheme to predict warfarin-associated hemorrhage: the ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study","volume":"58","author":"Fang","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2015.05.141_bb0140","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1182\/blood-2009-02-207928","article-title":"Outcomes and predictors of very stable INR control during chronic anticoagulation therapy","volume":"114","author":"Witt","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ijcard.2015.05.141_bb0145","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1586\/erc.12.148","article-title":"New oral anticoagulants for stroke prevention in atrial fibrillation: impact of gender, heart failure, diabetes mellitus and paroxysmal atrial fibrillation","volume":"10","author":"Ahmad","year":"2012","journal-title":"Expert. Rev. Cardiovasc. Ther."},{"key":"10.1016\/j.ijcard.2015.05.141_bb0150","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1161\/01.STR.27.9.1459","article-title":"Lifetime cost of stroke in the United States","volume":"27","author":"Taylor","year":"1996","journal-title":"Stroke"},{"key":"10.1016\/j.ijcard.2015.05.141_bb0155","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1161\/CIRCULATIONAHA.110.985655","article-title":"Cost-effectiveness of dabigatran for stroke prophylaxis in atrial fibrillation","volume":"123","author":"Shah","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2015.05.141_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-154-1-201101040-00289","article-title":"Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation","volume":"154","author":"Freeman","year":"2011","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijcard.2015.05.141_bb0165","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/eurheartj\/ehs157","article-title":"Cost-effectiveness of dabigatran compared with warfarin for patients with atrial fibrillation in Sweden","volume":"34","author":"Davidson","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2015.05.141_bb0170","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/bmj.321.7258.412","article-title":"Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study","volume":"32","author":"Adler","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.ijcard.2015.05.141_bb0175","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1161\/CIRCULATIONAHA.110.016337","article-title":"Blood pressure targets in subjects with Type 2 Diabetes mellitus\/impaired fasting glucose: observations from traditional and Bayesian random-effects meta-analyses of randomized trials","volume":"123","author":"Bangalore","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2015.05.141_bb0180","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1056\/NEJMoa021778","article-title":"Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes","volume":"348","author":"Gaede","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2015.05.141_bb0185","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0828-282X(06)70265-3","article-title":"Stroke in patients with atrial fibrillation: the diagnosis and hypertension by specialists","volume":"22","author":"Healey","year":"2006","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.ijcard.2015.05.141_bb0190","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1053\/j.ajkd.2011.11.015","article-title":"\u2018United States Renal Data System 2011 Annual Data Report: Atlas of Chronic Kidney Disease & End-Stage Renal Disease in the United States","volume":"59","author":"Collins","year":"2012","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.ijcard.2015.05.141_bb0195","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1001\/archinte.160.8.1093","article-title":"The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus","volume":"160","author":"Valmadrid","year":"2000","journal-title":"Arch. Intern. Med."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527315012255?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527315012255?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,25]],"date-time":"2019-08-25T15:32:23Z","timestamp":1566747143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527315012255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":39,"alternative-id":["S0167527315012255"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2015.05.141","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of dabigatran versus warfarin in diabetic patients with atrial fibrillation: Results from the RE-LY trial","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2015.05.141","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}